Use of Non-Vitamin K Antagonist Oral Anticoagulants (NOAC) in Non-Valvular Atrial Fibrillation - Province of British Columbia
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
Current status of oral anticoagulant adherence in Japanese patients with atrial fibrillation: A claims database analysis - Journal of Cardiology
Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide | SpringerLink
Anticoagulants | Health Navigator NZ
Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism – The SWAN Study | PLOS ONE
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin | Journal of the American Heart Association
PharmD on Twitter: "#GuideLines for switching between #Anticoagulants https://t.co/tmYuJDq6rm" / Twitter
Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study | BMC Medicine | Full Text
JCM | Free Full-Text | Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants | HTML
Oral anticoagulants: Optimizing venous thromboembolism management S. Aleidan FA - J Appl Hematol
Anticoagulant Comparison Chart
Rivaroxaban: a fully-subsidised oral anticoagulant
Updated Guidelines on Outpatient Anticoagulation | AAFP
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation | American Society of Nephrology
Moving towards ideal and appropriate models of anticoagulation management service Raphael A - Ann Afr Med
Oral Anticoagulation Management Cheat Sheet: Warfarin, ... | GrepMed
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
![PDF] When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f01cfb003b76789c5e1bc7cb09440d38d98a84b1/5-Table1-1.png "PDF] When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics | Semantic Scholar")
PDF] When to withhold oral anticoagulation in atrial fibrillation – an overview of frequent clinical discussion topics | Semantic Scholar
Switching between anticoagulant regimes; *half dose for edoxaban;... | Download Scientific Diagram
Pharmacistcoop - DOACs
Recommendation on how to switch between different anticoagulant regimens | Download Table
Guidance on use of Direct Oral Anti-Coagulants (DOACs) and warfarin in non- valvular Atrial Fibrillation Contents
OpenSAFELY: impact of national guidance on switching from warfarin to direct oral anticoagulants (DOACs) in early phase of COVID
The market for oral anticoagulants | Nature Reviews Drug Discovery
Direct Oral Anticoagulants for Secondary Stroke Prevention - Practical Neurology
